2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow XCEL-UMC-BETA: new trials by email Literature Review of XCEL-UMC-BETA trials Research Report on XCEL-UMC-BETA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 XCEL-UMC-BETA, Placebo - COVID-19, SARS-CoV 2 | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 26 | 2020-05-13 | 2023-01-26 |
| Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury XCEL-UMC-BETA, Placebo - Spinal Cord Injury, Chronic | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 10 | 2016-12-27 | 2020-02-17 |
Bronchiolitis Obliterans Syndrome (1) · COVID-19 (1) · Respiratory Distress Syndrome (1) · Spinal Cord Injuries (1)
Spain (2)
Antoni Torres, MD, PhD (1) · Joan Vidal, MD, PhD (1)